Peptide Based Infection Therapeutics Market Propels as Investment in Healthcare Sector Soars
As antibiotic resistance soar globally, there is an escalating pressure to come up with novel classes of antimicrobial compounds to fight infectious diseases. The application of slow release or efficient targeting drug delivery system in line with a therapeutic peptide may mitigate or reduce the need for excessive modification. As such, liposomal systems provide increased circulatory time of the encapsulated therapeutics and at the same time allowing targeting, at sites of infection or tumor growth. This has been used for...
View full press release